Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development (includes related party amounts of $175 and $1,430, respectively)	$ 11,479	$ 17,660
General and administrative (includes related party amounts of $3 and $0, respectively)	18,598	20,246
Total operating expenses	30,077	37,906
Loss from operations	(30,077)	(37,906)
Other income (expense):
Interest income	1,460	7
Interest expense	(9,217)	(2,759)
Other income (expense)	20	(7)
Total other expense	(7,737)	(2,759)
Net loss and comprehensive loss	$ (37,814)	$ (40,665)
Net loss per share, basic	$ (0.89)	$ (1.07)
Net loss per share, diluted	$ (0.89)	$ (1.07)
Weighted-average shares of common stock outstanding, basic	42,354,520	38,036,960
Weighted-average shares of common stock outstanding, diluted	42,354,520	38,036,960